Chong Kun Dang Pharmaceutical Corp. (185750) - Financial and Strategic SWOT Analysis Review

Chong Kun Dang Pharmaceutical Corp. (185750) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Chong Kun Dang Pharmaceutical Corp (CKD Pharma), manufactures, distributes, imports and exports prescription drugs, OTC drugs, health supplements and consumer health products. The company's product portfolio includes prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetes, as well as over-the-counter (OTC) drugs and health supplements. The company’s Chong Kun Dang Research Institute is characterized by three independent laboratories, namely, The New Drug Discovery Labs, The Technology Development Labs; and the Bio Research Labs. It has a manufacturing facility in Cheonan City, South Korea. The company has a global business presence, with a focus on markets in Asia, the Middle East, North Africa, and the European Union. CKD Pharma is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Chong Kun Dang Pharmaceutical Corp. - Key Facts
Chong Kun Dang Pharmaceutical Corp. - Key Employees
Chong Kun Dang Pharmaceutical Corp. - Key Employee Biographies
Chong Kun Dang Pharmaceutical Corp. - Major Products and Services
Chong Kun Dang Pharmaceutical Corp. - History
Chong Kun Dang Pharmaceutical Corp. - Company Statement
Chong Kun Dang Pharmaceutical Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Chong Kun Dang Pharmaceutical Corp. - Business Description
Product Category: Atojet
Performance
Product Category: Dilatren
Performance
Product Category: Gliatirin
Performance
Product Category: Januvia
Performance
Product Category: K Cap
Performance
Product Category: Other Products
Performance
Product Category: Prolia
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Korea
Performance
Geographical Segment: Others
Performance
Geographical Segment: Switzerland
Performance
R&D Overview
Chong Kun Dang Pharmaceutical Corp. - Corporate Strategy
Chong Kun Dang Pharmaceutical Corp. - SWOT Analysis
SWOT Analysis - Overview
Chong Kun Dang Pharmaceutical Corp. - Strengths
Chong Kun Dang Pharmaceutical Corp. - Weaknesses
Chong Kun Dang Pharmaceutical Corp. - Opportunities
Chong Kun Dang Pharmaceutical Corp. - Threats
Chong Kun Dang Pharmaceutical Corp. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Chong Kun Dang Pharmaceutical Corp., Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Chong Kun Dang Pharmaceutical Corp., Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Chong Kun Dang Pharmaceutical Corp., Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Chong Kun Dang Pharmaceutical Corp., Key Facts
Chong Kun Dang Pharmaceutical Corp., Key Employees
Chong Kun Dang Pharmaceutical Corp., Key Employee Biographies
Chong Kun Dang Pharmaceutical Corp., Major Products and Services
Chong Kun Dang Pharmaceutical Corp., History
Chong Kun Dang Pharmaceutical Corp., Other Locations
Chong Kun Dang Pharmaceutical Corp., Joint Venture
Chong Kun Dang Pharmaceutical Corp., Key Competitors
Chong Kun Dang Pharmaceutical Corp., Ratios based on current share price
Chong Kun Dang Pharmaceutical Corp., Annual Ratios
Chong Kun Dang Pharmaceutical Corp., Annual Ratios (Cont...1)
Chong Kun Dang Pharmaceutical Corp., Annual Ratios (Cont...2)
Chong Kun Dang Pharmaceutical Corp., Interim Ratios
Chong Kun Dang Pharmaceutical Corp., Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Chong Kun Dang Pharmaceutical Corp., Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Chong Kun Dang Pharmaceutical Corp., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Chong Kun Dang Pharmaceutical Corp., Performance Chart (2019 - 2023)
Chong Kun Dang Pharmaceutical Corp., Ratio Charts
Chong Kun Dang Pharmaceutical Corp., Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Chong Kun Dang Pharmaceutical Corp., Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings